Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Aug;56(2):141–142. doi: 10.1038/bjc.1987.172

Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer.

D M Watson 1, R A Hawkins 1, N J Bundred 1, H J Stewart 1, W R Miller 1
PMCID: PMC2002129  PMID: 2822069

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodwin J. S., Clair T., Cho-Chung Y. S. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors. J Natl Cancer Inst. 1980 Feb;64(2):395–398. doi: 10.1093/jnci/64.2.395. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Cho-Chung Y. S., Bodwin J. S., Clair T. Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression. Eur J Biochem. 1978 May;86(1):51–60. doi: 10.1111/j.1432-1033.1978.tb12283.x. [DOI] [PubMed] [Google Scholar]
  4. Cho-Chung Y. S., Redler B. H. Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression. Science. 1977 Jul 15;197(4300):272–275. doi: 10.1126/science.195337. [DOI] [PubMed] [Google Scholar]
  5. Edwards D. P., Chamness G. C., McGuire W. L. Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta. 1979 Dec 19;560(4):457–486. doi: 10.1016/0304-419x(79)90013-1. [DOI] [PubMed] [Google Scholar]
  6. Hawkins R. A., Black R., Steele R. J., Dixon J. M., Forrest A. P. Oestrogen receptor concentration in primary breast cancer and axillary node metastases. Breast Cancer Res Treat. 1981;1(3):245–251. doi: 10.1007/BF01806264. [DOI] [PubMed] [Google Scholar]
  7. Knight W. A., 3rd, Osborne C. K., Yochmowitz M. G., McGuire W. L. Steroid hormone receptors in the management of human breast cancer. Ann Clin Res. 1980 Oct;12(5):202–207. [PubMed] [Google Scholar]
  8. Kvinnsland S., Ekanger R., Døskeland S. O., Thorsen T. Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Res Treat. 1983;3(1):67–72. doi: 10.1007/BF01806235. [DOI] [PubMed] [Google Scholar]
  9. Leclercq G., Heuson J. C. Physiological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta. 1979 Dec 19;560(4):427–455. doi: 10.1016/0304-419x(79)90012-x. [DOI] [PubMed] [Google Scholar]
  10. Senbanjo R. O., Miller W. R., Hawkins R. A. Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity. Br J Cancer. 1986 Jul;54(1):127–130. doi: 10.1038/bjc.1986.162. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES